Trial Profile
A phase I study of aSeptiMab for the treatment of sepsis
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2015
Price :
$35
*
At a glance
- Drugs ASeptiMab (Primary)
- Indications Sepsis
- Focus Adverse reactions; Therapeutic Use
- 26 Jun 2015 New trial record